Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Otto, Matthias (VerfasserIn) , Krebs, Jörg (VerfasserIn) , Welker, Peter (VerfasserIn) , Holm, René (VerfasserIn) , Thiel, Manfred (VerfasserIn) , Gattinoni, Luciano (VerfasserIn) , Quintel, Michael (VerfasserIn) , Tsagogiorgas, Charalambos (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 March 2021
In: Pharmaceutics
Year: 2021, Jahrgang: 13, Heft: 3, Pages: 1-15
ISSN:1999-4923
DOI:10.3390/pharmaceutics13030431
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics13030431
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/13/3/431
Volltext
Verfasserangaben:Matthias Otto, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel and Charalambos Tsagogiorgas

MARC

LEADER 00000caa a2200000 c 4500
001 1764907760
003 DE-627
005 20230428014739.0
007 cr uuu---uuuuu
008 210729s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/pharmaceutics13030431  |2 doi 
035 |a (DE-627)1764907760 
035 |a (DE-599)KXP1764907760 
035 |a (OCoLC)1341420055 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Otto, Matthias  |d 1984-  |e VerfasserIn  |0 (DE-588)1237847168  |0 (DE-627)1764904648  |4 aut 
245 1 0 |a Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome  |c Matthias Otto, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel and Charalambos Tsagogiorgas 
264 1 |c 23 March 2021 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.07.2021 
520 |a Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) could address this problem. After induction of ARDS, 26 pigs were randomized into three groups: (1) control (Sham), (2) perfluorohexyloctane (F6H8), and (3) F6H8-ibuprofen. Using a nebulization catheter, (2) received 1 mL/kg F6H8 while (3) received 1 mL/kg F6H8 with 6 mg/mL ibuprofen. Ibuprofen plasma and lung tissue concentration, bronchoalveolar lavage (BAL) fluid concentration of TNF-α, IL-8, and IL-6, and lung mechanics were measured. The ibuprofen concentration was equally distributed to the dependent parts of the right lungs. Pharmacokinetic data demonstrated systemic absorption of ibuprofen proofing a transport across the alveolo-capillary membrane. A significantly lower TNF-α concentration was observed in (2) and (3) when compared to the control group (1). There were no significant differences in IL-8 and IL-6 concentrations and lung mechanics. F6H8 aerosol seemed to be a suitable carrier for pulmonary drug delivery to dependent ARDS lung regions without having negative effects on lung mechanics. 
650 4 |a aerosols 
650 4 |a drug carriers 
650 4 |a fluorocarbons 
650 4 |a inhalation 
650 4 |a respiratory distress syndrome 
650 4 |a tissue distribution 
700 1 |a Krebs, Jörg  |d 1978-  |e VerfasserIn  |0 (DE-588)131961713  |0 (DE-627)516320017  |0 (DE-576)298863081  |4 aut 
700 1 |a Welker, Peter  |e VerfasserIn  |4 aut 
700 1 |a Holm, René  |e VerfasserIn  |4 aut 
700 1 |a Thiel, Manfred  |d 1959-  |e VerfasserIn  |0 (DE-588)1029136874  |0 (DE-627)732482313  |0 (DE-576)376589213  |4 aut 
700 1 |a Gattinoni, Luciano  |e VerfasserIn  |4 aut 
700 1 |a Quintel, Michael  |e VerfasserIn  |4 aut 
700 1 |a Tsagogiorgas, Charalambos  |d 1974-  |e VerfasserIn  |0 (DE-588)129802255  |0 (DE-627)480699747  |0 (DE-576)297843044  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceutics  |d Basel : MDPI, 2009  |g 13(2021), 3, Artikel-ID 431, Seite 1-15  |h Online-Ressource  |w (DE-627)614096529  |w (DE-600)2527217-2  |w (DE-576)313958653  |x 1999-4923  |7 nnas  |a Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome 
773 1 8 |g volume:13  |g year:2021  |g number:3  |g elocationid:431  |g pages:1-15  |g extent:15  |a Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome 
856 4 0 |u https://doi.org/10.3390/pharmaceutics13030431  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1999-4923/13/3/431  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210729 
993 |a Article 
994 |a 2021 
998 |g 129802255  |a Tsagogiorgas, Charalambos  |m 129802255:Tsagogiorgas, Charalambos  |d 60000  |d 61600  |e 60000PT129802255  |e 61600PT129802255  |k 0/60000/  |k 1/60000/61600/  |p 8  |y j 
998 |g 1029136874  |a Thiel, Manfred  |m 1029136874:Thiel, Manfred  |d 60000  |d 61600  |e 60000PT1029136874  |e 61600PT1029136874  |k 0/60000/  |k 1/60000/61600/  |p 5 
998 |g 131961713  |a Krebs, Jörg  |m 131961713:Krebs, Jörg  |d 60000  |d 61600  |e 60000PK131961713  |e 61600PK131961713  |k 0/60000/  |k 1/60000/61600/  |p 2 
998 |g 1237847168  |a Otto, Matthias  |m 1237847168:Otto, Matthias  |d 60000  |d 61600  |e 60000PO1237847168  |e 61600PO1237847168  |k 0/60000/  |k 1/60000/61600/  |p 1  |x j 
999 |a KXP-PPN1764907760  |e 3958473237 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1764907760","id":{"doi":["10.3390/pharmaceutics13030431"],"eki":["1764907760"]},"name":{"displayForm":["Matthias Otto, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel and Charalambos Tsagogiorgas"]},"person":[{"family":"Otto","roleDisplay":"VerfasserIn","given":"Matthias","display":"Otto, Matthias","role":"aut"},{"family":"Krebs","roleDisplay":"VerfasserIn","display":"Krebs, Jörg","given":"Jörg","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Welker, Peter","given":"Peter","family":"Welker"},{"role":"aut","family":"Holm","roleDisplay":"VerfasserIn","given":"René","display":"Holm, René"},{"family":"Thiel","roleDisplay":"VerfasserIn","display":"Thiel, Manfred","given":"Manfred","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Gattinoni, Luciano","given":"Luciano","family":"Gattinoni","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Michael","display":"Quintel, Michael","family":"Quintel","role":"aut"},{"family":"Tsagogiorgas","display":"Tsagogiorgas, Charalambos","roleDisplay":"VerfasserIn","given":"Charalambos","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome","title_sort":"Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome"}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"23 March 2021"}],"note":["Gesehen am 29.07.2021"],"relHost":[{"id":{"issn":["1999-4923"],"zdb":["2527217-2"],"eki":["614096529"]},"recId":"614096529","name":{"displayForm":["Molecular Diversity Preservation International"]},"pubHistory":["1.2009 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"year":"2021","pages":"1-15","issue":"3","volume":"13","text":"13(2021), 3, Artikel-ID 431, Seite 1-15","extent":"15"},"title":[{"title_sort":"Pharmaceutics","title":"Pharmaceutics"}],"origin":[{"dateIssuedDisp":"2009-","publisher":"MDPI","publisherPlace":"Basel","dateIssuedKey":"2009"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 28.05.14"],"language":["eng"],"disp":"Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndromePharmaceutics"}],"physDesc":[{"extent":"15 S."}],"language":["eng"]} 
SRT |a OTTOMATTHIINHALATION2320